Myomo Past Earnings Performance

Past criteria checks 0/6

Myomo has been growing earnings at an average annual rate of 11.5%, while the Medical Equipment industry saw earnings growing at 4.5% annually. Revenues have been growing at an average rate of 32% per year.

Key information

11.48%

Earnings growth rate

69.07%

EPS growth rate

Medical Equipment Industry Growth4.25%
Revenue growth rate31.96%
Return on equity-26.80%
Net Margin-15.05%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Myomo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BST:0M61 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2539-6285
31 Dec 2433-6254
30 Sep 2425-8224
30 Jun 2421-9213
31 Mar 2420-9203
31 Dec 2319-8192
30 Sep 2319-8192
30 Jun 2317-9192
31 Mar 2315-11192
31 Dec 2216-11192
30 Sep 2216-12193
30 Jun 2216-11193
31 Mar 2215-11193
31 Dec 2114-11183
30 Sep 2114-9172
30 Jun 2111-10162
31 Mar 219-11142
31 Dec 208-12142
30 Sep 205-13132
30 Jun 204-13122
31 Mar 204-13122
31 Dec 194-12112
30 Sep 193-11112
30 Jun 193-11112
31 Mar 193-11112
31 Dec 182-10102
30 Sep 182-1092
30 Jun 182-882
31 Mar 182-1372
31 Dec 172-1362
30 Sep 171-1252
30 Jun 171-1242
31 Mar 171-541
31 Dec 161-431
30 Sep 161-431
30 Jun 161-431
31 Mar 161-431
31 Dec 151-431
31 Dec 141-431

Quality Earnings: 0M61 is currently unprofitable.

Growing Profit Margin: 0M61 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0M61 is unprofitable, but has reduced losses over the past 5 years at a rate of 11.5% per year.

Accelerating Growth: Unable to compare 0M61's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0M61 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (14.7%).


Return on Equity

High ROE: 0M61 has a negative Return on Equity (-26.8%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/25 16:56
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Myomo, Inc. is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Edward WooAscendiant Capital Markets LLC
Chase KnickerbockerCraig-Hallum Capital Group LLC